Cationic antiseptic compositions

Patent metadata

Field	Value
Publication number	US-11684069-B2
Application number	US-201414917185-A
Country	US
Kind code	B2
Filing date	Sep 11, 2014
Priority date	Sep 13, 2013
Publication date	Jun 27, 2023
Grant date	Jun 27, 2023

Abstract

An antiseptic composition comprising a multivalent cationic antiseptic present in an amount of 0.05 to 0.5 percent based upon the ready to use composition; an anionic compound which is water soluble in an amount of at least 0.1 grams in 100 grams water at 23 deg C., wherein the anionic compound is present at a concentration which would result in precipitation of the multivalent cationic antiseptic in the composition without a solubilizing surfactant present; wherein the composition, with the antiseptic, surfactant and anionic compound combined with each other, is free of precipitate.

First claim

The invention claimed is:

1. An antiseptic composition comprising:
a multivalent cationic antiseptic selected from the group consisting of chlorhexidine acetate, chlorhexidine gluconate, chlorhexidine lactate, chlorhexidine methosulfate, and polyhexamethylene biguanide hydrochloride, and a combination thereof,
wherein the multivalent cationic antiseptic is present in an amount of 0.05 to 0.5 percent based upon the weight of the antiseptic composition;
an anionic compound selected from sodium carboxymethyl cellulose, sodium saccharin, sodium phosphate, sodium bicarbonate, and a combination thereof,
wherein the anionic compound is present in an amount of at least 0.05 percent based the weight of the antiseptic composition; and
a solubilizing surfactant selected from the group consisting of zwitterionic surfactants, amine oxide surfactants, micelle-forming nonionic surfactants, and a combination thereof;
wherein the solubilizing surfactant is present in an amount greater than 80 wt-%, the anionic compound is present in an amount of less than 20 wt-%, and the multivalent cationic antiseptic is present in an amount of not more than 10 wt-%, wherein wt % is based upon the total weight of the combination of solubilizing surfactant, the anionic compound, and the multivalent cationic antiseptic, and
wherein the antimicrobial composition is free of precipitate according to Test Method A.

2. The antiseptic composition of claim 1 , wherein the solubilizing surfactant, the anionic compound, and the multivalent cationic antiseptic are present in amounts within the boundary defined by A 1 , J 1 , and K 1 , and along the boundary lines of A 1 -J 1 , J 1 -K 1 , and K 1 -A 1 of FIG. 1 of the accompanying drawings.

3. The antiseptic composition of claim 1 , wherein the solubilizing surfactant is an amine oxide surfactant.

4. The antiseptic composition of claim 3 , wherein the amine oxide surfactant is selected from compounds of the formula (R 14 ) 3 —N?O wherein R 14 is a (C1-C14)alkyl group, a (C6-C18)aralkyl, a (C6-C18)alkaryl group or a combination thereof, each of which is unsubstituted or substituted or interrupted at one or more carbon atoms by one or more N-, O-, or S-containing amido, ester, or hydroxyl groups and combinations thereof, and wherein each R 14 may be the same or different, and at least one R 14 group includes at least eight carbons.

5. The antiseptic composition of claim 4 , wherein the amine oxide surfactant is selected from the group consisting of (C8-C22)alkyldi(C1-C4)alkylamine oxides, (C8-C22)aralkyldi(C1-C4)alkylamine oxides, (C8-C22)alkaryldi(C1-C4)alkylamine oxides, (C8-C22)alkylamido(C2-C4)alkylenyldi(C1-C4)alkylamine oxides, (C8-C22)aralkylamido(C2-C4)alkylenyldi(C1-C4)alkylamine oxides, (C8-C22)alkarylamido(C2-C4)alkylenyldi(C1-C4)alkylamine oxides, and combinations thereof.

6. The antiseptic composition of claim 4 , wherein the amine oxide surfactant is selected from the group consisting of (C12-C16)alkyl(C1-C4)dialkylamine oxides, (C12-C16)alkylamido(C2-C4)alkylene(C1-4)dialkylamine oxides, and combinations thereof.

7. The antiseptic composition of claim 1 , wherein the zwitterionic surfactant is selected from the group consisting of (C8-C22) alkyl and alkenyl betaines, (C8-C22) aralkyl betaines, (C8-C22) alkaryl betaines, (C8-C22) alkyl and alkenyl sultaines, (C8-C22) aralkyl sultaines, (C8-C22) alkaryl sultaines, each of which is unsubstituted or substituted or interrupted at one or more carbon atoms by one or more N-, O-, or S-containing amido, ester, or hydroxyl groups and combinations thereof.

8. The antiseptic composition of claim 1 , wherein the anionic compound is present in an amount of at least 0.1 percent based upon the ready to use composition.

9. The antiseptic composition of claim 1 , wherein the anionic compound is present in an amount of at least 1.2 wt-%, based upon the total weight of the solubilizing surfactant, the anionic compound, and the multivalent cationic antiseptic.

Assignees

• 3M Innovative Properties Company

Inventors

• Parthasarathy Ranjani V
• Scholz Matthew T
• Xiong Joshua X
• Heapy Catherine D

Classifications

• A61K8/39

  Derivatives containing from 2 to 10 oxyalkylene groups · CPC title

• A61K8/442

  substituted by amido group(s) · CPC title

• A61L26/0066

  Medicaments; Biocides · CPC title

• A61L2300/404

  Biocides, antimicrobial agents, antiseptic agents · CPC title

• A61Q17/005

  Antimicrobial preparations · CPC title